BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21059207)

  • 1. The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression.
    Murray MJ; Saini HK; van Dongen S; Palmer RD; Muralidhar B; Pett MR; Piipari M; Thornton CM; Nicholson JC; Enright AJ; Coleman N
    Mol Cancer; 2010 Nov; 9():290. PubMed ID: 21059207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets.
    Palmer RD; Murray MJ; Saini HK; van Dongen S; Abreu-Goodger C; Muralidhar B; Pett MR; Thornton CM; Nicholson JC; Enright AJ; Coleman N;
    Cancer Res; 2010 Apr; 70(7):2911-23. PubMed ID: 20332240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biology of childhood germ cell tumours, focussing on the significance of microRNAs.
    Murray MJ; Nicholson JC; Coleman N
    Andrology; 2015 Jan; 3(1):129-39. PubMed ID: 25303610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance.
    Jeyapalan JN; Noor DA; Lee SH; Tan CL; Appleby VA; Kilday JP; Palmer RD; Schwalbe EC; Clifford SC; Walker DA; Murray MJ; Coleman N; Nicholson JC; Scotting PJ
    Br J Cancer; 2011 Aug; 105(4):575-85. PubMed ID: 21712824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric malignant germ cell tumors show characteristic transcriptome profiles.
    Palmer RD; Barbosa-Morais NL; Gooding EL; Muralidhar B; Thornton CM; Pett MR; Roberts I; Schneider DT; Thorne N; Tavaré S; Nicholson JC; Coleman N;
    Cancer Res; 2008 Jun; 68(11):4239-47. PubMed ID: 18519683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross platform analysis of methylation, miRNA and stem cell gene expression data in germ cell tumors highlights characteristic differences by tumor histology.
    Poynter JN; Bestrashniy JR; Silverstein KA; Hooten AJ; Lees C; Ross JA; Tolar J
    BMC Cancer; 2015 Oct; 15():769. PubMed ID: 26497383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruption.
    Bailey S; Ferraresso M; Alonso-Crisostomo L; Ward D; Smith S; Nicholson JC; Saini H; Enright AJ; Scarpini CG; Coleman N; Murray MJ
    Br J Cancer; 2023 Oct; 129(9):1451-1461. PubMed ID: 37789102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumours.
    Wruck W; Bremmer F; Kotthoff M; Fichtner A; Skowron MA; Schönberger S; Calaminus G; Vokuhl C; Pfister D; Heidenreich A; Albers P; Adjaye J; Nettersheim D
    J Cell Mol Med; 2021 Feb; 25(3):1394-1405. PubMed ID: 33448076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.
    Murray MJ; Bell E; Raby KL; Rijlaarsdam MA; Gillis AJ; Looijenga LH; Brown H; Destenaves B; Nicholson JC; Coleman N
    Br J Cancer; 2016 Jan; 114(2):151-62. PubMed ID: 26671749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LIN28 Expression in malignant germ cell tumors downregulates let-7 and increases oncogene levels.
    Murray MJ; Saini HK; Siegler CA; Hanning JE; Barker EM; van Dongen S; Ward DM; Raby KL; Groves IJ; Scarpini CG; Pett MR; Thornton CM; Enright AJ; Nicholson JC; Coleman N;
    Cancer Res; 2013 Aug; 73(15):4872-84. PubMed ID: 23774216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small non-coding RNA sequencing reveals global dysregulation of piwi-interacting RNA (piRNA) expression in gonadal malignant germ cell tumours.
    Laidlaw S; Alonso-Crisostomo L; Bailey S; Saini HK; Molnár A; Nicholson JC; Enright AJ; Scarpini CG; Rahbari R; Coleman N; Murray MJ;
    Andrology; 2023 May; 11(4):738-755. PubMed ID: 36254403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in DNA methylation profiles by histologic subtype of paediatric germ cell tumours: a report from the Children's Oncology Group.
    Williams LA; Mills L; Hooten AJ; Langer E; Roesler M; Frazier AL; Krailo M; Nelson HH; Bestrashniy J; Amatruda JF; Poynter JN
    Br J Cancer; 2018 Oct; 119(7):864-872. PubMed ID: 30287918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.
    Ernst S; Heinzelmann J; Bohle RM; Weber G; Stöckle M; Junker K; Heinzelbecker J
    Andrology; 2020 Nov; 8(6):1687-1698. PubMed ID: 32530514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput microRNAome analysis in human germ cell tumours.
    Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW; Sun Y; Chen C; Guenther S; Sherlock J; Veltman I; Baeten J; van der Spek PJ; de Alarcon P; Looijenga LH
    J Pathol; 2007 Nov; 213(3):319-28. PubMed ID: 17893849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors.
    Hsieh TH; Liu YR; Chang TY; Liang ML; Chen HH; Wang HW; Yen Y; Wong TT
    Neuro Oncol; 2018 Mar; 20(4):519-530. PubMed ID: 29036598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA and transcription factor co-regulatory networks and subtype classification of seminoma and non-seminoma in testicular germ cell tumors.
    Qin G; Mallik S; Mitra R; Li A; Jia P; Eischen CM; Zhao Z
    Sci Rep; 2020 Jan; 10(1):852. PubMed ID: 31965022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric primary central nervous system germ cell tumors of different prognosis groups show characteristic miRNome traits and chromosome copy number variations.
    Wang HW; Wu YH; Hsieh JY; Liang ML; Chao ME; Liu DJ; Hsu MT; Wong TT
    BMC Genomics; 2010 Feb; 11():132. PubMed ID: 20178649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy.
    Jung M; Mollenkopf HJ; Grimm C; Wagner I; Albrecht M; Waller T; Pilarsky C; Johannsen M; Stephan C; Lehrach H; Nietfeld W; Rudel T; Jung K; Kristiansen G
    J Cell Mol Med; 2009 Sep; 13(9B):3918-28. PubMed ID: 19228262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EPCAM-A novel molecular target for the treatment of pediatric and adult germ cell tumors.
    Schönberger S; Okpanyi V; Calaminus G; Heikaus S; Leuschner I; Nicholson JC; Stoecklein NH; Schneider DT; Borkhardt A
    Genes Chromosomes Cancer; 2013 Jan; 52(1):24-32. PubMed ID: 22987628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.